
Sign up to save your podcasts
Or


Kirk Huntsman, CEO of Vivos Therapeutics, gives hope for sleep apnea, a condition that an estimated 39 million US adults suffer through, and how taking charge of our health quite literally starts with our breathing.
All that, plus the Flava of the Week about F45 teaming up to add GLP-1 medications to its on-demand fitness and nutrition tools. How does it work, and why should we cheer on similar offerings that lead consumers down the path to better health?
This show is produced by the Consumer-First Health Group, the community for consumer-centered health enthusiasts. (#398)
See omnystudio.com/listener for privacy information.
By Shift Forward Health4.6
1616 ratings
Kirk Huntsman, CEO of Vivos Therapeutics, gives hope for sleep apnea, a condition that an estimated 39 million US adults suffer through, and how taking charge of our health quite literally starts with our breathing.
All that, plus the Flava of the Week about F45 teaming up to add GLP-1 medications to its on-demand fitness and nutrition tools. How does it work, and why should we cheer on similar offerings that lead consumers down the path to better health?
This show is produced by the Consumer-First Health Group, the community for consumer-centered health enthusiasts. (#398)
See omnystudio.com/listener for privacy information.

9,586 Listeners

112,946 Listeners

73 Listeners

9,202 Listeners

165,790 Listeners

149 Listeners

57 Listeners

66 Listeners

9,957 Listeners

57,911 Listeners

146 Listeners

1 Listeners

104 Listeners

20 Listeners

9 Listeners